MPW posts Q4 net loss of $664M ($1.11/shr); includes $772M Steward impairments

MEDICAL PROPERTIES TRUST INC

2023-FY EPS reported -$0.93 revenue$871,799,000

Q4 2023 NFFO of $0.36/shr; full-year NFFO $1.59/shr, down from $1.82/shr in 2022.
Agreed to sell five hospitals to Prime Healthcare for $350M at 7.4% cap rate in Feb 2024.
Steward and International JV moved to cash basis accounting effective Jan 1, 2024.
FY2024 guidance not provided due to uncertainty around Steward and liquidity transactions.
Sold MEDIAN/Priory term loan for ~$115M; targeting at least $2B incremental liquidity in 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MEDICAL PROPERTIES TRUST INC reported the fiscal year ended December 31, 2023 results: EPS ($0.93) per share.

Period: the fiscal year ended December 31, 2023
EPS: ($0.93) per share
Result: reported results

Exact text from the filing

net loss of ($0.93) and NFFO of $1.59 for the full-year 2023

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MEDICAL PROPERTIES TRUST INC reported the fourth quarter ended December 31, 2023 results: EPS ($1.11) per share.

Period: the fourth quarter ended December 31, 2023
EPS: ($1.11) per share
Result: reported results

Exact text from the filing

Net loss of ($1.11) and Normalized Funds from Operations ("NFFO") of $0.36 for the 2023 fourth quarter

View on SEC.gov

Browse all earnings releases →

MEDICAL PROPERTIES TRUST INC filing history →

Source: SEC EDGAR

accession 0001193125-24-040842

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.